Growth Marketing Partners Growth Marketing Partners Book a diagnostic

For private equity and VC

Close the growth gap in your value-creation plan.

For operating partners, investors and portfolio CEOs at PE- and VC-backed B2B software and fintech companies. A three-week diagnostic, a 90-day plan and senior operators who make growth happen inside the hold period.

The numbers on your desk

The value-creation plan

Growth targets that hold up in the next board review.

Organic growth

Revenue built from the go-to-market engine, not just cost cuts.

Exit readiness

Efficient, repeatable growth a buyer will pay a multiple for.

What we hear from investors

The cost levers are pulled. Growth is next.

Firms lean on cost and operations levers, while growth strategies stay underused or stall in execution. With fewer exits and less M&A, organic growth has to carry more of the plan.

9%

of private equity leaders name M&A their top value-creation priority for 2025. It ranked last of ten levers.

FTI Consulting PE Value Creation Index, 2025

95%

of the time, the winning vendor was already on the buyer's day-one shortlist. Portfolio growth starts with getting on that list.

6sense Buyer Experience Report, 2025

20 yrs

of B2B marketing behind every engagement, including growth roles at PE- and VC-backed software companies.

Our founder, J. Christopher Kenny

How we work with your portfolio

One method, with each company's own team.

We work inside the portfolio company, alongside its leadership, and report in a format the deal team can use. The same method travels across companies, while each one gets a plan built from its own data.

Operating partner

A clear read on where growth is stuck and a scorecard that rolls up to the value-creation plan.

Portfolio CEO

A senior partner who helps run the plan, not another adviser handing over slides.

CRO or CMO

Extra senior capacity and a plan they own, or cover while you hire one.

CFO

CAC payback and pipeline by program, in a format the board recognizes.

The board

A constraint memo in three weeks and progress reported against it every month.

The first 90 days

A growth plan before the next board meeting.

Days 1–21

Diagnose

Funnel, pricing and channel economics rebuilt from the CRM, with a board-ready constraint memo the company keeps.

Days 22–45

Focus

Segments, positioning, pricing moves and a pipeline model tied to the value-creation plan.

Days 46–90

Build

Programs live, the first tests read out and a monthly scorecard for the deal team.

Questions

What investors ask us.

Can you work across several portfolio companies?

Yes. The method and scorecard stay the same, so results are comparable across the portfolio, while each company gets its own diagnosis and plan.

Can you cover a gap while we hire a CMO or CRO?

Yes. We can keep growth moving while you search, help define the role from what the diagnostic finds, then hand a working plan to whoever you hire.

How soon after close can you start?

As soon as we have CRM access and time with the leadership team. The diagnostic takes three weeks, which fits inside most 100-day plans.

Do you work with VC-backed companies too?

Yes. Growth-stage, venture-backed B2B software and fintech companies face the same question: how to grow efficiently enough for the next round. The work is the same.

How do you report progress?

A monthly scorecard built from the company's CRM: qualified pipeline by program, win rate, CAC payback and net revenue retention, tracked against the plan.

Next step

Ready to put growth back in the plan?

Tell us about the company, its targets and where growth has stalled. We'll tell you where we'd start.